Gestational length assignment based on last menstrual period, first trimester crown-rump length, ovulation, and implantation timing

por Mahendru, Amita A., Wilhelm-Benartzi , Charlotte S., Wilkinson, Ian B., McEniery, Carmel M., Johnson, Sarah, Lees, Christoph
Publicado 2016

NY-ESO-1 expression in DCIS: A new predictor of good prognosis

por Coombes, R. Charles, Caballero, Otavia L., Shousha, Sami, Ghaem-Maghami, Sadaf, Woodley-Barker, Laura, Wilhelm-Benartzi, Charlotte S., Neville, A. Munro
Publicado 2017

Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues

por Shenker, Natalie S, Flower, Kirsty J, Wilhelm-Benartzi, Charlotte S, Dai, Wei, Bell, Emma, Gore, Edmund, El Bahrawy, Mona, Weaver, Gillian, Brown, Robert, Flanagan, James M
Publicado 2015

In Utero Exposures, Infant Growth, and DNA Methylation of Repetitive Elements and Developmentally Related Genes in Human Placenta

por Wilhelm-Benartzi, Charlotte S., Houseman, E. Andres, Maccani, Matthew A., Poage, Graham M., Koestler, Devin C., Langevin, Scott M., Gagne, Luc A., Banister, Carolyn E., Padbury, James F., Marsit, Carmen J.
Publicado 2011

P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT...

por Russell, Nigel, Cumming, Oliver, Othman, Jad, Dillon, Richard, Potter, Nicola, Wilhelm-Benartzi, Charlotte, Jovanovic, Jelena, Gilkes, Amanda, Batten, Leona, Canham, Joanna, Laura Hinson, Emily, Kottaridis, Panagiotis, Cavenagh, Jamie, Arnold, Claire, Dennis, Mike, Knapper, Steven
Publicado 2023

Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer

por Willenbrock, Frances, Cox, Catrin M., Parkes, Eileen E., Wilhelm-Benartzi, Charlotte S., Abraham, Aswin G., Owens, Robert, Sabbagh, Ahmad, Jones, Christopher M., Hughes, Daniel L. I., Maughan, Tim, Hurt, Christopher N., O’Neill, Eric E., Mukherjee, Somnath
Publicado 2020

S134: FLAG-IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 T...

por Russell, Nigel, Othman, Jad, Dillon, Richard, Potter, Nicola, Wilhelm-Benartzi, Charlotte, Knapper, Steven, Batten, Leona, Canham, Joanna, Hinson, Emily Laura, Malthe Overgaard, Ulrik, Gilkes, Amanda, Mehta, Priyanka, Kottaridis, Panagiotis, Cavenagh, Jamie, Hemmaway, Claire, Arnold, Claire, Freeman, Sylvie, Dennis, Mike
Publicado 2023

Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study

por Phelps, David L, Borley, Jane V, Flower, Kirsty J, Dina, Roberto, Darb-Esfahani, Silvia, Braicu, Ioana, Sehouli, Jalid, Fotopoulou, Christina, Wilhelm-Benartzi, Charlotte S, Gabra, Hani, Yazbek, Joseph, Chatterjee, Jayanta, Ip, Jacey, Khan, Harun, Likos-Corbett, Marina-Therese, Brown, Robert, Ghaem-Maghami, Sadaf
Publicado 2017

P503: A RANDOMISED TRIAL OF MOLECULAR MONITORING VERSUS STANDARD CLINICAL CARE IN YOUNGER ADULTS WITH ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE UK NCRI AML17 AND AML19 STUDIES

por Potter, Nicola, Jovanovic, Jelena, Ivey, Adam, Thomas, Abin, Wilhelm-Benartzi, Charlotte, Gilkes, Amanda, Thomas, Ian, Johnson, Sean, Canham, Joanna, Knapper, Steven, Khwaja, Asim, Frances Mcmullin, Mary, Cavenagh, Jamie, Malthe Overgaard, Ulrik, Clark, Richard, Solomon, Ellen, Freeman, Sylvie, Hills, Robert, Burnett, Alan, Russell, Nigel, Dillon, Richard
Publicado 2023

A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial

por Othman, Jad, Wilhelm-Benartzi, Charlotte, Dillon, Richard, Knapper, Steve, Freeman, Sylvie D., Batten, Leona M., Canham, Joanna, Hinson, Emily L., Wych, Julie, Betteridge, Sophie, Villiers, William, Kleeman, Michelle, Gilkes, Amanda, Potter, Nicola, Overgaard, Ulrik Malthe, Mehta, Priyanka, Kottaridis, Panagiotis, Cavenagh, Jamie, Hemmaway, Claire, Arnold, Claire, Dennis, Mike, Russell, Nigel H.
Publicado 2023

Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagn...

por Wilhelm-Benartzi, Charlotte S, Miller, Sarah E, Bruggraber, Sylvaine, Picton, Diane, Wilson, Mark, Gatley, Katrina, Chhabra, Anita, Marcovecchio, M Loredana, Hendriks, A Emile J, Morobé, Hilde, Chmura, Piotr Jaroslaw, Bond, Simon, Aschemeier-Fuchs, Bärbel, Knip, Mikael, Tree, Timothy, Overbergh, Lut, Pall, Jaivier, Arnaud, Olivier, Haller, Michael J, Nitsche, Almut, Schulte, Anke M, Mathieu, Chantal, Mander, Adrian, Dunger, David
Publicado 2021